CoChat

Pharmacotherapy for post traumatic stress disorder (PTSD)

Open access
Williams, Taryn, Phillips, Nicole J, Stein, Dan J, Ipser, Jonathan C · 2022 · Cochrane Database of Systematic Reviews
Cited by 73

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Posttraumatic stress disorder (PTSD) is a prevalent and disabling disorder. Evidence that PTSD is characterised by specific psychobiological dysfunctions has contributed to a growing interest in the use of medication in its treatment. OBJECTIVES: To assess the effects of medication for reducing PTSD symptoms in adults with PTSD. SEARCH METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL; Issue 11, November 2020); MEDLINE (1946-), Embase (1974-), PsycINFO (1967-) and PTSDPubs (all available years) either directly or via the Cochrane Common Mental Disorders Controlled Trials Register (CCMDCTR). We also searched international trial registers. The date of the latest search was 13 November 2020. SELECTION CRITERIA: All randomised controlled trials (RCTs) of pharmacotherapy for adults with PTSD. DATA COLLECTION AND ANALYSIS: Three review authors (TW, JI, and NP) independently assessed RCTs for inclusion in the review, collated trial data, and assessed trial quality. We contacted investigators to obtain missing data. We stratified summary statistics by medication class, and by medication agent for all medications. We calculated dichotomous and continuous measures using a random-effects model, and assessed heterogeneity. MAIN RESULTS: We include 66 RCTs in the review (range: 13 days to 28 weeks; 7442 participants; age range 18 to 85 years) and 54 in the meta-analysis. For the primary outcome of treatment response, we found evidence of beneficial effect for selective serotonin reuptake inhibitors (SSRIs) compared with placebo (risk ratio (RR) 0.66, 95% confidence interval (CI) 0.59 to 0.74; 8 studies, 1078 participants), which improved PTSD symptoms in 58% of SSRI participants compared with 35% of placebo participants, based on moderate-certainty evidence. For this outcome we also found evidence of beneficial effect for the noradrenergic and specific serotonergic antidepressant (NaSSA) mirtazapine: (RR 0.45, 95% CI 0.22 to 0.94; 1 study, 26 participants) in 65% of people on mirtazapine compared with 22% of placebo participants, and for the tricyclic antidepressant (TCA) amitriptyline (RR 0.60, 95% CI 0.38 to 0.96; 1 study, 40 participants) in 50% of amitriptyline participants compared with 17% of placebo participants, which improved PTSD symptoms. These outcomes are based on low-certainty evidence. There was however no evidence of beneficial effect for the number of participants who improved with the antipsychotics (RR 0.51, 95% CI 0.16 to 1.67; 2 studies, 43 participants) compared to placebo, based on very low-certainty evidence. For the outcome of treatment withdrawal, we found evidence of a harm for the individual SSRI agents compared with placebo (RR 1.41, 95% CI 1.07 to 1.87; 14 studies, 2399 participants). Withdrawals were also higher for the separate SSRI paroxetine group compared to the placebo group (RR 1.55, 95% CI 1.05 to 2.29; 5 studies, 1101 participants). Nonetheless, the absolute proportion of individuals dropping out from treatment due to adverse events in the SSRI groups was low (9%), based on moderate-certainty evidence. For the rest of the medications compared to placebo, we did not find evidence of harm for individuals dropping out from treatment due to adverse events. AUTHORS' CONCLUSIONS: The findings of this review support the conclusion that SSRIs improve PTSD symptoms; they are first-line agents for the pharmacotherapy of PTSD, based on moderate-certainty evidence. The NaSSA mirtazapine and the TCA amitriptyline may also improve PTSD symptoms, but this is based on low-certainty evidence. In addition, we found no evidence of benefit for the number of participants who improved following treatment with the antipsychotic group compared to placebo, based on very low-certainty evidence. There remain important gaps in the evidence base, and a continued need for more effective agents in the management of PTSD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/14651858.cd002795.pub3

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 241

  1. Ahmadpanah, 2014, Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder, Neuropsychobiology, 69, 235-42, 10.1159/000362243 · DOI · Paper page
  2. Baker, 1995, A double-blind randomized placebo-controlled multi-center study of brofaromine in the treatment of post-traumatic stress disorder, Psychopharmacology, 122, 386, 10.1007/BF02246271 · DOI
  3. Connor, 2001, Predictors of treatment response in patients with posttraumatic stress disorder, Progress in Neuro-Psychopharmacology & Biological Psychiatry, 25, 337, 10.1016/S0278-5846(00)00163-9 · DOI
  4. Becker, 2007, A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 27, 193, 10.1097/JCP.0b013e318032eaed · DOI · Paper page
  5. Brady, 2000, Efficacy and safety of sertraline treatment of posttraumatic stress disorder, Archives of General Psychiatry, 283, 1837
  6. Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study, American Journal of Psychiatry, 158, 1974, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
  7. Davidson, 2002, Characterizing the effects of sertraline in post-traumatic stress disorder, Psychological Medicine, 32, 661, 10.1017/S0033291702005469 · DOI
  8. Gaffney, 2003, Factor analysis of treatment response in posttraumatic stress disorder, Journal of Traumatic Stress, 16, 77, 10.1023/A:1022067512964 · DOI
  9. Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59, 10.4088/JCP.v63n0112 · DOI · Paper page
  10. Rapaport, 2000, Quality of life improvement in PTSD with sertraline treatment: results of a multicenter, placebo-controlled trial, International Journal of Neuropsychopharmacology, 3, 294
  11. Braun, 1990, Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment, Journal of Clinical Psychiatry, 51, 236
  12. Butterfield, 2001, Olanzapine in the treatment of post-traumatic stress disorder: a pilot study, International Clinical Psychopharmacology, 16, 197, 10.1097/00004850-200107000-00003 · DOI · Paper page
  13. Chung, 2004, Efficacy and tolerability of mirtazapine and sertraline in Korean veterans with posttraumatic stress disorder: a randomized open label trial, Human Psychopharmacology, 19, 489-94, 10.1002/hup.615 · DOI
  14. Barnett, 2002, Tolerability of fluoxetine in posttraumatic stress disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 26, 363, 10.1016/S0278-5846(01)00282-2 · DOI
  15. Connor, 1999, Fluoxetine in post-traumatic stress disorder: randomized, double-blind study, British Journal of Psychiatry, 175, 17, 10.1192/bjp.175.1.17 · DOI · Paper page
  16. Malik, 1999, Quality-of-life and posttraumatic stress disorder: a pilot study assessing changes in SF-36 scores before and after treatment in a placebo- controlled trial of fluoxetine, Journal of Traumatic Stress, 12, 387, 10.1023/A:1024745030140 · DOI · Paper page
  17. Connor, 2006, Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment, Psychopharmacology, 184, 21-5, 10.1007/s00213-005-0265-3 · DOI
  18. Davidson, 1990, Treatment of posttraumatic stress disorder with amitriptyline and placebo, Archives of General Psychiatry, 47, 259, 10.1001/archpsyc.1990.01810150059010 · DOI · Paper page
  19. Davidson, 1993, Predicting response to amitriptyline in posttraumatic stress disorder, American Journal of Psychiatry, 150, 1024, 10.1176/ajp.150.7.1024 · DOI · Paper page
  20. Davidson, 2000, Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 292
  21. Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo controlled study, American Journal of Psychiatry, 158, 1974-81, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
  22. Davidson, 2002, Characterizing the effects of sertraline in post-traumatic stress disorder, Psychological Medicine, 32, 661, 10.1017/S0033291702005469 · DOI
  23. Davidson, 2001, Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder, Archives of General Psychiatry, 58, 485, 10.1001/archpsyc.58.5.485 · DOI · Paper page
  24. Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59-65
  25. Davidson, 2000, Double-blind, randomized, 28-week continuation study of sertraline and placebo in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 292
  26. Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study, American Journal of Psychiatry, 158, 1974, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
  27. Rapaport, 2002, Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment, Journal of Clinical Psychiatry, 63, 59, 10.4088/JCP.v63n0112 · DOI · Paper page
  28. Davidson, 2003, Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial, Biological Psychiatry, 53, 188, 10.1016/S0006-3223(02)01411-7 · DOI · Paper page
  29. Davidson, 2005, Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study, Journal of Clinical Psychopharmacology, 25, 166-9, 10.1097/01.jcp.0000155817.21467.6c · DOI · Paper page
  30. Davidson, 2006, Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial, Archives of General Psychiatry, 63, 1158, 10.1001/archpsyc.63.10.1158 · DOI · Paper page
  31. Davidson, 2006, Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study, Journal of Clinical Psychopharmacology, 26, 259, 10.1097/01.jcp.0000222514.71390.c1 · DOI · Paper page
  32. Davidson, 2007, The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder, Journal of Clinical Psychopharmacology, 27, 85-8, 10.1097/JCP.0b013e31802e5115 · DOI · Paper page
  33. Davis, 2004, A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study, Journal of Clinical Psychopharmacology, 24, 291, 10.1097/01.jcp.0000125685.82219.1a · DOI · Paper page
  34. Davis, 2008, Divalproex in the treatment of posttraumatic tress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population, Journal of Clinical Psychopharmacology, 28, 84-8, 10.1097/jcp.0b013e318160f83b · DOI · Paper page
  35. Davis, 2020, A randomized, placebo-controlled trial of mirtazapine for the treatment of posttraumatic stress disorder in v eterans, Journal of Clinical Psychiatry, 81, e1, 10.4088/JCP.20m13267 · DOI
  36. Friedman, 2007, Randomised, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting, Journal of Clinical Psychiatry, 68, 711, 10.4088/JCP.v68n0508 · DOI · Paper page
  37. Hamner, 2008, A preliminary controlled trial of divalproex in posttraumatic stress disorder, Annals of Clinical Psychiatry, 21, 89
  38. Hertzberg, 1999, A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder, Biological Psychiatry, 45, 1226, 10.1016/S0006-3223(99)00011-6 · DOI · Paper page
  39. Hertzberg, 2000, Lack of efficacy for fluoxetine in PTSD: a placebo controlled trial in combat veterans, Annals of Clinical Psychiatry, 12, 101, 10.3109/10401230009147096 · DOI · Paper page
  40. Kaplan, 1996, Inositol treatment of posttraumatic stress disorder, Anxiety, 2, 51-2, 10.1002/(SICI)1522-7154(1996)2:1<51::AID-ANXI8>3.0.CO;2-G · DOI
  41. Connor, 2001, Predictors of treatment response in patients with posttraumatic stress disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 337-45, 10.1016/S0278-5846(00)00163-9 · DOI
  42. Katz, 1994, Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic, Anxiety, 1, 169-74, 10.1002/anxi.3070010404 · DOI
  43. Kosten, 1991, Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine, Journal of Nervous and Mental Disease, 179, 366-70, 10.1097/00005053-199106000-00011 · DOI · Paper page
  44. Li, 2017, Effect and safety of sertraline for treat posttraumatic stress disorder: a multicenter randomised controlled study, International Journal of Psychiatry in Clinical Practice, 21, 151, 10.1080/13651501.2017.1291838 · DOI
  45. Marshall, 2001, Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study, American Journal of Psychiatry, 158, 1982, 10.1176/appi.ajp.158.12.1982 · DOI · Paper page
  46. Marshall R Blanco C Lewis-Fernandez R Simpson B Lin SH Garcia W Randomized controlled trial of paroxetine in adults with chronic PTSD 18th Annual Meeting, International Society for Traumatic Stress Studies, November 7 - 10, Baltimore, MD 2002 · DOI
  47. Martenyi, 2002, Fluoxetine versus placebo in posttraumatic stress disorder, Journal of Clinical Psychiatry, 63, 199, 10.4088/JCP.v63n0305 · DOI · Paper page
  48. Martenyi, 2002, Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder, British Journal of Psychiatry, 181, 315, 10.1192/bjp.181.4.315 · DOI · Paper page
  49. Martenyi, 2007, Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study, Journal of Clinical Psychopharmacology, 27, 166-70, 10.1097/JCP.0b013e31803308ce · DOI · Paper page
  50. Mathew, 2011, A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial, European Neuropsychopharmacology, 21, 221-9, 10.1016/j.euroneuro.2010.11.012 · DOI · Paper page
  51. McCall, 2018, A randomized controlled trial (RCT) of prazosin versus placebo for suicidal posttraumatic stress disorder (PTSD) patients with nightmares-a pilot study, Sleep, 41, A351, 10.1097/JCP.0000000000000968 · DOI
  52. McRae, 2004, Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder, Depression and Anxiety, 19, 190-6, 10.1002/da.20008 · DOI · Paper page
  53. Padala, 2006, Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women, International Clinical Psychopharmacology, 21, 275-80, 10.1097/00004850-200609000-00005 · DOI
  54. Panahi, 2011, A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder, Psychological Medicine, 41, 2159-66, 10.1017/S0033291711000201 · DOI · Paper page
  55. Friedman, 2007, Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting, Journal of Clinical Psychiatry, 68, 711, 10.4088/JCP.v68n0508 · DOI · Paper page
  56. Rasmusson, 2017, A randomized controlled trial of ganaxolone in posttraumatic stress disorder, Psychopharmacology, 234, 2245-57, 10.1007/s00213-017-4649-y · DOI
  57. Reich, 2004, A preliminary study of risperidone in the treatment of posttraumatic stress disorder related to childhood abuse in women, Journal of Clinical Psychiatry, 65, 1601, 10.4088/JCP.v65n1204 · DOI · Paper page
  58. Reist, 1995, REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder, Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 433, 10.1016/0278-5846(95)00024-P · DOI
  59. Reist, 1989, A controlled trial of desipramine in 18 men with posttraumatic stress disorder, American Journal of Psychiatry, 146, 513, 10.1176/ajp.146.4.513 · DOI · Paper page
  60. Saygin, 2002, Nefazodone versus sertraline in treatment of posttraumatic stress disorder, Bulletin of Clinical Psychopharmacology, 12, 1
  61. Shestatzky, 1988, A controlled trial of phenelzine in posttraumatic stress disorder, Psychiatric Research, 24, 149, 10.1016/0165-1781(88)90057-1 · DOI · Paper page
  62. Stein, 2003, Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies, Expert Opinion on Pharmacotherapy, 4, 1829, 10.1517/14656566.4.10.1829 · DOI · Paper page
  63. Spivak, 2006, Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial, Journal of Clinical Psychopharmacology, 26, 152-6, 10.1097/01.jcp.0000203195.65710.f0 · DOI · Paper page
  64. Tucker, 2001, Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial, Journal of Clinical Psychiatry, 62, 860, 10.4088/JCP.v62n1105 · DOI · Paper page
  65. Tucker, 2003, Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo, General Psychopharmacology, 37, 135
  66. Tucker, 2007, Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study, Journal of Clinical Psychiatry, 68, 201, 10.4088/JCP.v68n0204 · DOI
  67. Van der Kolk, 1994, Fluoxetine treatment in posttraumatic stress disorder, Journal of Clinical Psychiatry, 55, 517
  68. Van der Kolk, 2007, A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance, Journal of Clinical Psychiatry, 68, 37, 10.4088/JCP.v68n0105 · DOI · Paper page
  69. Villarreal, 2016, Efficacy of quetiapine monotherapy in posttraumatic stress disorder: a randomized, placebo-controlled trial, American Journal of Psychiatry, 173, 1205, 10.1176/appi.ajp.2016.15070967 · DOI · Paper page
  70. Yeh, 2011, A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD, CNS Neuroscience and Therapeutics, 17, 305-10, 10.1111/j.1755-5949.2010.00188.x · DOI · Paper page
  71. Amital, 2000, A placebo-controlled study of sertraline in posttraumatic stress disorder, International Journal of Neuropsychopharmacology, 3, 269
  72. Zohar, 2002, Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 22, 190, 10.1097/00004714-200204000-00013 · DOI · Paper page
  73. Aerni, 2004, Low-dose cortisol for symptoms of posttraumatic stress disorder, American Journal of Psychiatry, 161, 1488, 10.1176/appi.ajp.161.8.1488 · DOI · Paper page
  74. Angelidis, 2019, P.3.26 Effects of hydrocortisone on cognitive performance and threat-interference under acute stress in highly anxious females, European Neuropsychopharmacology, 29, S698, 10.1016/j.euroneuro.2019.01.088 · DOI
  75. Back, 2016, A double-blind, randomized, controlled pilot trial of N-Acetylcysteine in veterans with posttraumatic stress disorder and substance use disorders, Journal of Clinical Psychiatry, 77, e1439, 10.4088/JCP.15m10239 · DOI · Paper page
  76. Back, 2018, Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: design and methodology of a randomized controlled trial in military veterans, Contemporary Clinical Trials, 73, 8, 10.1016/j.cct.2018.08.009 · DOI
  77. Bartzokis, 2005, Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder, Biological Psychiatry, 57, 474, 10.1016/j.biopsych.2004.11.039 · DOI · Paper page
  78. Batki, 2014, Topiramate treatment of alcohol use disorder in veterans with PTSD: a randomized controlled pilot trial, Alcoholism: Clinical and Experimental Research, 38, 2169-77, 10.1111/acer.12496 · DOI · Paper page
  79. Boroughs, 2018, Posttraumatic stress symptoms and emerging adult sexual minority men: implications for assessment and treatment of childhood sexual abuse, Journal of Traumatic Stress, 31, 665, 10.1002/jts.22335 · DOI
  80. Starr, 2019, Prospective study of the effectiveness of paroxetine on the onset of posttraumatic stress disorder, depression, and health and functional outcomes after trauma, Journal of Orthopaedic Trauma, 33, e58, 10.1097/BOT.0000000000001342 · DOI
  81. Bountress, 2018, Treatment of co-occurring posttraumatic stress disorder and substance use: does order of onset influence outcomes?, Psychological Trauma: Theory, Research, Practice and Policy, 10, 662, 10.1037/tra0000309 · DOI
  82. Brady, 2005, Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder, Alcoholism: Clinical and Experimental Research, 29, 395-401, 10.1097/01.ALC.0000156129.98265.57 · DOI
  83. Bremner, 1997, Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder, Archives of General Psychiatry, 54, 246, 10.1001/archpsyc.1997.01830150070011 · DOI · Paper page
  84. Brunet, 2018, Reduction of PTSD symptoms with pre-reactivation propranolol therapy: a randomized controlled trial, American Journal of Psychiatry, 175, 427, 10.1176/appi.ajp.2017.17050481 · DOI · Paper page
  85. Buhmann, 2018, Long-term treatment effect of trauma-affected refugees with flexible cognitive behavioural therapy and antidepressants, Psychiatry Research, 264, 217, 10.1016/j.psychres.2018.03.069 · DOI
  86. Coupland, 1997, A pilot controlled study of the effects of flumazenil in posttraumatic stress disorder, Biological Psychiatry, 41, 988, 10.1016/S0006-3223(97)00043-7 · DOI
  87. Flanagan, 2018, Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder, Experimental and Clinical Psychopharmacology, 26, 391, 10.1037/pha0000197 · DOI
  88. Flanagan, 2019, Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder, Experimental and Clinical Psychopharmacology, 27, 45, 10.1037/pha0000232 · DOI
  89. Frank, 1988, A randomized clinical trial of phenelzine and imipramine for post-traumatic stress disorder, American Journal of Psychiatry, 145, 1289, 10.1176/ajp.145.10.1289 · DOI · Paper page
  90. Frijling, 2017, Preventing PTSD with oxytocin: effects of oxytocin administration on fear neurocircuitry and PTSD symptom development in recently trauma-exposed individuals, European Journal of Psychotraumatology, 8, 1302652, 10.1080/20008198.2017.1302652 · DOI
  91. Gelpin, 1996, Treatment of recent trauma survivors with benzodiazepines: a prospective study, Journal of Clinical Psychiatry, 57, 390
  92. Graham, 2018, High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder, British Journal of Psychiatry, 213, 704, 10.1192/bjp.2018.211 · DOI
  93. Hamner, 1997, Buspirone potentiation of antidepressants in the treatment of PTSD, Depression and Anxiety, 5, 137, 10.1002/(SICI)1520-6394(1997)5:3<137::AID-DA6>3.0.CO;2-B · doi:10.1002/(sici)1520-6394(1997)5:3<137::aid-da6>3.0.co;2-b
  94. Hamner, 1999, Procaine administration and behavioral responsivity in post-traumatic stress disorder: a pilot study of tolerability, Human Psychopharmacology, 14, 105, 10.1002/(SICI)1099-1077(199903)14:2<105::AID-HUP75>3.0.CO;2-E · doi:10.1002/(sici)1099-1077(199903)14:2<105::aid-hup75>3.0.co;2-e
  95. Hamner, 2003, Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms, International Clinical Psychopharmacology, 18, 1
  96. Inslicht, 2018, Randomized controlled trial of hydrocortisone and D-cycloserine on fear extinction in PTSD, Biological Psychiatry, 83, S352, 10.1016/j.biopsych.2018.02.905 · DOI
  97. Jacobs-Rebhun, 2000, Posttraumatic stress disorder and sleep difficulty, American Journal of Psychiatry, 157, 1525, 10.1176/appi.ajp.157.9.1525 · DOI
  98. Kanter, 2001, Glucocorticoid feedback sensitivity and adrenocortical responsiveness in posttraumatic stress disorder, Biological Psychiatry, 50, 238, 10.1016/S0006-3223(01)01158-1 · DOI
  99. Kellner, 2000, Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder, Biological Psychiatry, 47, 107, 10.1016/S0006-3223(99)00118-3 · DOI
  100. Le, 2018, Effects of treatment, choice, and preference on health-related quality-of-life outcomes in patients with posttraumatic stress disorder (PTSD), Quality of Life Research, 27, 1555, 10.1007/s11136-018-1833-4 · DOI
  101. Mello, 2009, A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder, BMC Psychiatry, 9, 1, 10.1186/1471-244X-9-28 · DOI
  102. Monnelly, 2003, Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 23, 193, 10.1097/00004714-200304000-00012 · DOI · Paper page
  103. Grillon, 1995, Yohimbine facilitated acoustic startle in combat veterans with post-traumatic stress disorder, Psychopharmacology, 117, 466, 10.1007/BF02246220 · DOI
  104. Naylor, 2013, A pilot randomized controlled trial with paroxetine for subthreshold PTSD in operation enduring freedom/operation Iraqi freedom era veterans, Psychiatry Research Journal, 206, 318-20, 10.1016/j.psychres.2012.11.008 · DOI
  105. Neylan, 2006, No improvement of posttraumatic stress disorder symptoms with guanfacine treatment, American Journal of Psychiatry, 163, 2186-8, 10.1176/ajp.2006.163.12.2186 · DOI · Paper page
  106. Pape, 2018, DNA methylation levels are associated with CRF1 receptor antagonist treatment outcome in women with post-traumatic stress disorder, Clinical Epigenetics, 10, 136, 10.1186/s13148-018-0569-x · DOI
  107. Petrakis, 2006, Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder, Biological Psychiatry, 60, 777, 10.1016/j.biopsych.2006.03.074 · DOI
  108. Pollack, 2011, Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial, Journal of Clinical Psychiatry, 72, 892, 10.4088/JCP.09m05607gry · DOI · Paper page
  109. Ramaswamy, 2016, Failed efficacy of ziprasidone in the treatment of post-traumatic stress disorder, Contemporary Clinical Trials Communications, 2, 1, 10.1016/j.conctc.2015.12.003 · DOI
  110. Randall, 1995, Effects of the benzodiazepine antagonist flumazenil in PTSD, Biological Psychiatry, 38, 319, 10.1016/0006-3223(94)00306-N · DOI · Paper page
  111. Raskind, 2003, Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study, American Journal of Psychiatry, 160, 371, 10.1176/appi.ajp.160.2.371 · DOI · Paper page
  112. Raskind, 2007, A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder, Society of Biological Psychiatry, 61, 928-34, 10.1016/j.biopsych.2006.06.032 · DOI · Paper page
  113. Raskind, 2013, A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan, American Journal of Psychiatry, 170, 1003, 10.1176/appi.ajp.2013.12081133 · DOI · Paper page
  114. Reist, 1995, REM latency, dexamethasone suppression test, and thyroid releasing hormone stimulation test in posttraumatic stress disorder, Progress in Neuropsychopharmacology and Biological Psychiatry, 19, 433, 10.1016/0278-5846(95)00024-P · DOI
  115. Reist, 2001, Beta-adrenergic blockade and emotional memory in PTSD, International Journal of Neuropsychopharmacology, 4, 377, 10.1017/S1461145701002607 · DOI · Paper page
  116. Schelling, 2004, Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study, Biological Psychiatry, 55, 627, 10.1016/j.biopsych.2003.09.014 · DOI · Paper page
  117. Southwick, 1997, Noradrenergic and serotonergic function in posttraumatic stress disorder, Archives of General Psychiatry, 54, 749, 10.1001/archpsyc.1997.01830200083012 · DOI · Paper page
  118. Stein, 2002, Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study, American Journal of Psychiatry, 159, 1777, 10.1176/appi.ajp.159.10.1777 · DOI · Paper page
  119. Suris, 2017, Facilitating fear-based memory extinction with dexamethasone: a randomized controlled trial in male veterans with combat-related PTSD, Psychiatry, 80, 399, 10.1080/00332747.2017.1286892 · DOI
  120. Van der Kolk, 1989, Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder, Psychopharmacology Bulletin, 25, 417
  121. Verplaetse, 2019, Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder, Alcoholism: Clinical and Experimental Research, 43, 741, 10.1111/acer.13969 · DOI
  122. Albucher, 2002, Psychopharmacological treatment in PTSD: a critical review, Journal of Psychiatric Research, 36, 355, 10.1016/S0022-3956(02)00058-4 · DOI
  123. Amos, 2014, Pharmacological interventions for preventing post-traumatic stress disorder (PTSD), Cochrane Database of Systematic Reviews, 10.1002/14651858.CD006239.pub2 · DOI · Paper page
  124. American Psychiatric Association, 1980, Diagnostic and statistical manual of mental disorders (DSM-III)
  125. American Psychiatric Association, 1994, Diagnostic and statistical manual of mental disorders (DSM-IV)
  126. American Psychiatric Association, 2013, Diagnostic and statistical manual of mental Disorders, fifth edition, 10.1176/appi.books.9780890425596 · DOI · Paper page
  127. Asnis, 2004, SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations, Drugs, 64, 383, 10.2165/00003495-200464040-00004 · DOI · Paper page
  128. 1999, The promise and problems of meta-analysis, New England Journal of Medicine, 337, 559
  129. Baker, 2003, Quantitative analysis of sponsorship bias in economic studies of antidepressants, British Journal of Psychiatry, 183, 498, 10.1192/03-2 · DOI · Paper page
  130. Ballenger, 2000, Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety, Journal of Clinical Psychiatry, 61, 60
  131. Ballenger, 2004, Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety, Journal of Clinical Psychiatry, 65, 55
  132. Bandelow, 2008, World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-raumatic tress disorders -first revision, World Journal of Biological Psychiatry, 9, 248, 10.1080/15622970802465807 · DOI · Paper page
  133. Basoglu, 1992, Amitriptyline for PTSD in a torture survivor: a case study, Journal of Traumatic Stress, 5, 77, 10.1007/BF00976812 · DOI
  134. Beck, 1961, An inventory for measuring depression, Archives of General Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
  135. Bernardy, 2017, Pharmacological management of posttraumatic stress disorder, Current Opinion in Psychology, 14, 116, 10.1016/j.copsyc.2017.01.003 · DOI
  136. Blake, 1990, A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1, Behavior Therapy, 21, 187
  137. Bleich, 1986, Post-traumatic stress disorder following combat exposure: clinical features and psychopharmacological treatment, British Journal of Psychiatry, 149, 365, 10.1192/bjp.149.3.365 · DOI · Paper page
  138. Bradley, 2005, A multidimensional meta-analysis of psychotherapy for PTSD, American Journal of Psychiatry, 162, 214, 10.1176/appi.ajp.162.2.214 · DOI · Paper page
  139. Bremner, 2004, Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder, Annals of the New York Academy of Science, 1032, 154, 10.1196/annals.1314.012 · DOI
  140. Breslau, 1991, Traumatic events and post traumatic stress disorder in an urban population of young adults, Archives of General Psychiatry, 48, 216, 10.1001/archpsyc.1991.01810270028003 · DOI · Paper page
  141. Brom, 1989, Brief psychotherapy for posttraumatic stress disorders, Journal of Consulting and Clinical Psychology, 57, 607, 10.1037/0022-006X.57.5.607 · doi:10.1037/0022-006x.57.5.607 · Paper page
  142. Brophy, 1991, Cyproheptadine for combat nightmares in post-traumatic stress disorder and dream anxiety disorder, Military Medicine, 156, 100, 10.1093/milmed/156.2.100 · DOI
  143. Brunello, 2001, Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment, Neuropsychobiology, 43, 150, 10.1159/000054884 · DOI · Paper page
  144. Burstein, 1984, Treatment of posttraumatic stress disorder with imipramine, Psychosomatics, 25, 681, 10.1016/S0033-3182(84)72977-X · DOI
  145. Burton, 1999, Categorizing fear: the role of trauma in a clinical formulation, American Journal of Psychiatry, 156, 761, 10.1176/ajp.156.5.761 · DOI
  146. Canive, 1997, MRI reveals gross structural abnormalities in PTSD, Annals of the New York Academy of Sciences, 821, 512, 10.1111/j.1749-6632.1997.tb48318.x · DOI
  147. Canive, 1998, Bupropion treatment in veterans with posttraumatic stress disorder: an open study, Journal of Clinical Psychopharmacology, 18, 379, 10.1097/00004714-199810000-00005 · DOI
  148. Charney, 1993, Psychobiologic mechanisms of posttraumatic stress disorder, Archives of General Psychiatry, 50, 294, 10.1001/archpsyc.1993.01820160064008 · DOI · Paper page
  149. Chen, 1991, The obsessive quality and clomipramine treatment of PTSD, American Journal of Psychiatry, 148, 1087, 10.1176/ajp.148.8.1087 · DOI
  150. Connor, 1998, The role of serotonin in posttraumatic stress disorder: neurobiology and pharmacotherapy, CNS Spectrums, 3, 43
  151. Connor, 1999, A pilot study of mirtazapine in post-traumatic stress disorder, International Clinical Psychopharmacology, 14, 29, 10.1097/00004850-199901000-00003 · DOI · Paper page
  152. Covi, 1984, Primary depression or primary anxiety: a possible psychometric approach to a diagnostic dilemma, Clinical Neuropharmacology, 7, S502, 10.1097/00002826-198406001-00458 · DOI
  153. Creamer, 2003, Psychometric properties of the Impact of Event Scale-Revised, Behaviour Research and Therapy, 41, 1489-96, 10.1016/j.brat.2003.07.010 · DOI · Paper page
  154. Cyr, 2000, Treatment for posttraumatic stress disorder, Annals of Pharmacotherapy, 34, 366, 10.1345/aph.19120 · doi:10.1345/aph.19120 · Paper page
  155. Davidson, 1987, A pilot study of phenelzine in the treatment of post-traumatic stress disorder, British Journal of Psychiatry, 150, 252, 10.1192/bjp.150.2.252 · DOI
  156. Davidson, 1989, Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions, Psychopharmacology Bulletin, 25, 422
  157. Davidson, 1993, Predicting response to amitriptyline in posttraumatic stress disorder, American Journal of Psychiatry, 150, 1024, 10.1176/ajp.150.7.1024 · DOI · Paper page
  158. Davidson, 1997, Response characteristics to antidepressants and placebo in post-traumatic stress disorder, International Clinical Psychopharmacology, 12, 291, 10.1097/00004850-199711000-00001 · DOI · Paper page
  159. Davidson, 1997, Biological therapies for posttraumatic stress disorder: an overview, Journal of Clinical Psychiatry, 58, 33
  160. Davidson, 1997, Assessment of a new self-rating scale for posttraumatic stress disorder, Psychological Medicine, 27, 153, 10.1017/S0033291796004229 · DOI · Paper page
  161. Davidson, 1998, Fluvoxamine in civilians with posttraumatic stress disorder, Journal of Clinical Psychopharmacology, 18, 93, 10.1097/00004714-199802000-00020 · DOI · Paper page
  162. Davidson, 2000, Pharmacotherapy of posttraumatic stress disorder: treatment options, long term follow-up, and predictors of outcome, Journal of Clinical Psychiatry, 61, 52
  163. Davis, 2000, Nefazodone treatment for chronic posttraumatic stress disorder: an open trial, Journal of Clinical Psychopharmacology, 20, 159, 10.1097/00004714-200004000-00007 · DOI · Paper page
  164. Deeks, 2001, Systematic Reviews in Health Care: Meta-Analysis in Context
  165. Deeks, 2003, The Cochrane Library
  166. Deeks, 2008, Egger M, Davey SG, Altman DG editor(s). Systematic Reviews in Health Care: Meta-Analysis in Context. 2nd Edition, 285-12
  167. De Jong, 2001, Lifetime events and posttraumatic stress disorder in 4 postconflict settings, JAMA, 286, 555, 10.1001/jama.286.5.555 · DOI · Paper page
  168. Dillard, 1993, Use of thioridazine in post-traumatic stress disorder, Southern Medical Journal, 86, 1276, 10.1097/00007611-199311000-00022 · DOI
  169. Dow, 1997, Antidepressant treatment of posttraumatic stress disorder and major depression in veterans, Annals of Clinical Psychiatry, 9, 1, 10.3109/10401239709147767 · doi:10.3109/10401239709147767
  170. Duffy, 1992, Rapid response to buspirone in a case of post-traumatic stress disorder, Annals of Clinical Psychiatry, 4, 193, 10.3109/10401239209149571 · DOI
  171. Duffy, 1994, Efficacy of buspirone in the treatment of posttraumatic stress disorder: An open trial, Annals of Clinical Psychiatry, 6, 33, 10.3109/10401239409148837 · DOI · Paper page
  172. Falcon, 1985, Tricyclics: possible treatment for post-traumatic stress disorder, Journal of Clinical Psychiatry, 46, 385
  173. Famularo, 1988, Propranolol treatment for childhood posttraumatic stress disorder, acute type. A pilot study, American Journal of Diseases of Children, 142, 1244, 10.1001/archpedi.1988.02150110122036 · DOI · Paper page
  174. Fesler, 1991, Valproate in combat-related posttraumatic stress disorder, Journal of Clinical Psychiatry, 52, 361
  175. Fichtner, 1990, Decreased episodic violence and increased control of dissociation in a carbamazepine-treated case of multiple personality, Biological Psychiatry, 27, 1045, 10.1016/0006-3223(90)90040-9 · DOI
  176. Fichtner, 1994, Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response, Life Sciences, 54, 39, 10.1016/0024-3205(94)00592-3 · DOI
  177. Foa, 1999, The expert consensus guideline series: treatment of posttraumatic stress disorder: the expert consensus panel for PTSD, Journal of Clinical Psychiatry, 60, 1
  178. Ford, 1996, The use of anticonvulsants in posttraumatic stress disorder: case study and overview, Journal of Traumatic Stress, 9, 857, 10.1002/jts.2490090413 · doi:10.1002/jts.2490090413
  179. Forster, 1994, Lithium for irritability in post-traumatic stress disorder, Journal of Traumatic Stress, 8, 143, 10.1002/jts.2490080110 · doi:10.1002/jts.2490080110
  180. Franco, 2016, Generalizability of pharmacologic and psychotherapy clinical trial results for posttraumatic stress disorder to community samples, Journal of Clinical Psychiatry, 77, 975, 10.4088/JCP.15m10060 · DOI · Paper page
  181. Gersons, 2000, Randomized clinical trial of brief eclectic psychotherapy for police officers with posttraumatic stress disorder, Journal of Trauma Stress, 13, 333, 10.1023/A:1007793803627 · DOI · Paper page
  182. Gilboa-Schechtman, 2010, Prolonged exposure versus dynamic therapy for adolescent PTSD: a pilot randomized controlled trial, Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1034, 10.1016/j.jaac.2010.07.014 · DOI · Paper page
  183. Gist, 2015, Encyclopaedia of Clinical Psychology
  184. Glover, 1993, A preliminary trial of nalmefene for the treatment of emotional numbing in combat veterans with post-traumatic stress disorder, Israel Journal of Psychiatry and Related Sciences, 30, 255
  185. Gupta, 1998, Efficacy of cyproheptadine for nightmares associated with posttraumatic stress disorder, Comprehensive Psychiatry, 39, 160, 10.1016/S0010-440X(98)90076-1 · DOI
  186. Gury, 1999, Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability, Encephale, 25, 470
  187. Guy, 1976, ECDEU assessment manual for psychopharmacology
  188. Hamilton, 1959, The assessment of anxiety states by rating, British Journal of Medical Psychology, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page
  189. Hamilton, 1960, A rating scale for depression, Journal of Neurology, Neurosurgery & Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
  190. Hamner, 1996, Clozapine treatment for a veteran with comorbid psychosis and PTSD (letter), American Journal of Psychiatry, 153, 841, 10.1176/ajp.153.6.841 · DOI
  191. Hamner, 1998, Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder, International Clinical Psychopharmacology, 13, 233, 10.1097/00004850-199809000-00008 · DOI
  192. Harmon, 1996, Clonidine for posttraumatic stress disorder in preschool children, Journal of the American Academy of Child & Adolescent Psychiatry, 35, 1247, 10.1097/00004583-199609000-00022 · DOI · Paper page
  193. Hertzberg, 1996, Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design, Journal of Clinical Psychopharmacology, 16, 294, 10.1097/00004714-199608000-00004 · DOI
  194. Hertzberg, 1998, Open trial of nefazodone for combat-related posttraumatic stress disorder, Journal of Clinical Psychiatry, 59, 460, 10.4088/JCP.v59n0904 · DOI · Paper page
  195. Hidalgo, 1999, Nefazodone in posttraumatic stress: results from six open-label trials, International Clinical Psychopharmacology, 14, 61, 10.1097/00004850-199903000-00001 · DOI · Paper page
  196. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  197. Hogben, 1981, Treatment of traumatic war neurosis with phenelzine, Archives of General Psychiatry, 38, 440, 10.1001/archpsyc.1981.01780290074008 · DOI · Paper page
  198. Horrigan, 1996, Guanfacine for PTSD nightmares, Journal of the American Academy of Child & Adolescent Psychiatry, 35, 975, 10.1097/00004583-199608000-00006 · DOI
  199. Irwin, 1989, Pharmacologic treatment of veterans with posttraumatic stress disorder and concomitant affective disorder, Annals of Clinical Psychiatry, 1, 127, 10.3109/10401238909149968 · DOI
  200. Izrayelit, 1998, Schizoaffective disorder and PTSD successfully treated with olanzapine and supportive psychotherapy, Psychiatric Annals, 28, 424, 10.3928/0048-5713-19980801-04 · DOI

200 of 241 shown

Cited by

See all 73

Metadata

Authors
Williams, T., Phillips, N. J., Stein, D. J., & Ipser, J. C.
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2022-03-02
Volume
2022
Issue
3
Pages
CD002795-CD002795
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W4214870542
Cited by
73
References
36
FWCI
12.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacotherapy for post traumatic stress disorder (PTSD). https://app.cochat.ai/papers/10.1002/14651858.cd002795.pub3
The paper
Williams, T., Phillips, N. J., Stein, D. J., & Ipser, J. C. (2022). Pharmacotherapy for post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd002795.pub3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.